Your browser doesn't support javascript.
loading
Letter in Response to "HIF-Prolyl Hydroxylase Inhibitors: Confirmed Efficacy with Uncertain Safety".
Yamamoto, Hiroyasu; Nobori, Kiyoshi; Matsuda, Yoshimi; Hayashi, Yasuhiro; Hayasaki, Takanori; Akizawa, Tadao.
Affiliation
  • Yamamoto H; Division of Nephrology and Hypertension, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Nobori K; Research and Development Japan, Bayer Yakuhin, Ltd., Osaka, Japan.
  • Matsuda Y; Research and Development Japan, Bayer Yakuhin, Ltd., Osaka, Japan.
  • Hayashi Y; Medical Affairs and Pharmacovigilance, Bayer Yakuhin, Ltd., Osaka, Japan.
  • Hayasaki T; Medical Affairs and Pharmacovigilance, Bayer Yakuhin, Ltd., Osaka, Japan.
  • Akizawa T; Division of Nephrology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Am J Nephrol ; 52(12): 977-978, 2021.
Article in En | MEDLINE | ID: mdl-34727543
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prolyl-Hydroxylase Inhibitors / Anemia Limits: Humans Language: En Journal: Am J Nephrol Year: 2021 Document type: Article Affiliation country: Japan
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prolyl-Hydroxylase Inhibitors / Anemia Limits: Humans Language: En Journal: Am J Nephrol Year: 2021 Document type: Article Affiliation country: Japan